Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

THMA

Thimble Point Acquisition (THMA)

Thimble Point Acquisition Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:THMA
DataHoraFonteTítuloCódigoCompanhia
02/05/202314:37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:THMAThimble Point Acquisition Corporation
12/04/202317:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:THMAThimble Point Acquisition Corporation
10/04/202317:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:THMAThimble Point Acquisition Corporation
31/03/202317:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:THMAThimble Point Acquisition Corporation
09/02/202318:43Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:THMAThimble Point Acquisition Corporation
24/01/202318:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:THMAThimble Point Acquisition Corporation
10/01/202318:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:THMAThimble Point Acquisition Corporation
04/01/202318:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:THMAThimble Point Acquisition Corporation
04/01/202308:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:THMAThimble Point Acquisition Corporation
03/01/202309:38Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:THMAThimble Point Acquisition Corporation
14/11/202219:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:THMAThimble Point Acquisition Corporation
16/06/202217:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:THMAThimble Point Acquisition Corporation
02/05/202217:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:THMAThimble Point Acquisition Corporation
02/05/202217:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:THMAThimble Point Acquisition Corporation
29/03/202207:07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:THMAThimble Point Acquisition Corporation
14/02/202208:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:THMAThimble Point Acquisition Corporation
23/12/202118:41Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:THMAThimble Point Acquisition Corporation
13/12/202118:31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:THMAThimble Point Acquisition Corporation
13/12/202118:17Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:THMAThimble Point Acquisition Corporation
03/12/202118:12Business WirePear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics CompanyNASDAQ:THMAThimble Point Acquisition Corporation
30/11/202119:05Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:THMAThimble Point Acquisition Corporation
23/11/202110:00Business WirePear Therapeutics to Participate in Evercore ISI Fourth Annual HealthCONx ConferenceNASDAQ:THMAThimble Point Acquisition Corporation
22/11/202118:52Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:THMAThimble Point Acquisition Corporation
22/11/202110:00Business WirePear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use DisorderNASDAQ:THMAThimble Point Acquisition Corporation
15/11/202110:02Business WirePear Therapeutics Provides 2021 Business Update and Reaffirms Full Year 2021 Revenue GuidanceNASDAQ:THMAThimble Point Acquisition Corporation
15/11/202110:00Business WireThimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business PlanNASDAQ:THMAThimble Point Acquisition Corporation
09/11/202110:00Business WirePear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product ListNASDAQ:THMAThimble Point Acquisition Corporation
08/11/202118:05Business WirePear Therapeutics to Participate in the BTIG Digital Health ForumNASDAQ:THMAThimble Point Acquisition Corporation
25/10/202110:21Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:THMAThimble Point Acquisition Corporation
09/09/202109:35Business WirePear and Thimble Point Announce Nominees to Board of DirectorsNASDAQ:THMAThimble Point Acquisition Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:THMA